Financial Incentives for Smoking Treatment II (FIESTA II)

University of California, Los Angeles (UCLA)

Status: Invitation-only

Conditions: Tobacco Use Cessation; Smoking Cessation

Treatments: Behavioral: Smoking cessation counseling (Quitline); Behavioral: Financial incentives for use of evidence-based smoking cessation therapies; Behavioral: Financial incentives for smoking cessation; Behavioral: Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy)

Study type: Interventional

Funder types: Other

Identifiers

NCT03979885

R01DA045688-01A1

Details and patient eligibility

About

Financial incentives for motivating changes in health behavior, particularly for smoking and other morbid habits, are increasingly being tested by health insurers, employers, and government agencies. However, in using incentive programs for smoking cessation, key unanswered structural and theoretical questions remain regarding their effectiveness, acceptability to patients, and economic sustainability. This trial aims to advance the science and implementation of financial incentives for smoking cessation interventions among high-risk, hospitalized smokers. The investigators will pursue two specific aims: 1) comparing the impact of three approaches for smoking cessation on smoking abstinence, use of evidenced-based therapy, and quality of life and 2) comparing the short-term and long term return on investment of using goal directed and outcome-based financial incentives to promote smoking cessation.

Enrollment: 1,058 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. age ≥ 18 years
2. smoked tobacco during the prior 30 days,
3. have an active U.S. phone number and address,
4. can provide consent in English or Spanish and
5. are in at least the contemplative stage of change for quitting smoking, as assessed by a single measure, readiness to quit

Exclusion criteria

1. use only smokeless tobacco,
2. are pregnant or breastfeeding,
3. are discharged to an institution (e.g., nursing home, long-term care facility),
4. are unable to provide informed consent, or do not have cognitive ability to enroll or participate in the study

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

1,058 participants in 3 patient groups

Goal-Directed Incentives

Other group

Treatment:

Behavioral: Smoking cessation counseling (Quitline)

Behavioral: Financial incentives for use of evidence-based smoking cessation therapies

Behavioral: Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy)

Outcome-Based Incentives

Other group

Treatment:

Behavioral: Smoking cessation counseling (Quitline)

Behavioral: Financial incentives for smoking cessation

Behavioral: Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy)

Enhanced Usual Care

Other group

Treatment:

Behavioral: Smoking cessation counseling (Quitline)

Behavioral: Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy)